 |
 |
 |
 |
|
|
|
|
 |
|
|
 |
|
|
|
|
| |
|||||||||||||||||
|
|
|
|
|
|
|
|||||||||||
|
|||||||||||||||||
|
Correction
|
|
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
|
|
|
Correction, Vol. 11, No. 8In "Laboratory Exposures to Brucellae and Implications for Bioterrorism" by Pablo Yagupsky and Ellen Jo Baron, an error occurred in the dosage for rifampin prophylaxis. In the second sentence of the fourth paragraph under the heading "Postexposure Prophylaxis," the correct dosage of rifampin is 600 mg once daily. The corrected text appears in the updated article at http://www.cdc.gov/ncidod/EID/vol11no08/04-1197.htm We regret any confusion this error may have caused.
|
|
|
||||||
|
||||||
|
|
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
|
|
|
This page posted October
17, 2005 |
|
|
|
|
Emerging
Infectious Diseases Journal |
|
|